[Statins are safe in patients with liver diseases and may have a beneficial effect]

Area of Science:

• Pharmacology
• Hepatology
• Clinical Medicine

Background:

• The Danish Medicines Agency advises routine liver enzyme monitoring for patients on statins to prevent liver injury.
• Statins are widely prescribed cholesterol-lowering medications with a well-established safety profile.

Purpose of the Study:

• To review the evidence regarding the necessity of routine liver enzyme monitoring in patients treated with statins.
• To evaluate the safety and potential benefits of statins in patients with chronic liver disease.

Main Methods:

• Systematic review of existing scientific literature and clinical studies.
• Analysis of data on the incidence of severe drug-induced hepatic injury associated with statin use.
• Evaluation of recent research on the effects of statins in patients with pre-existing liver conditions.

Main Results:

• Evidence indicates that severe drug-induced hepatic injury from statins is extremely rare.
• No data currently support the claim that routine liver enzyme monitoring improves the prevention or detection of statin-induced liver injury.
• Recent studies suggest statins are safe for patients with chronic liver disease and may offer therapeutic benefits.

Conclusions:

• Routine liver enzyme monitoring for statin-treated patients is not evidence-based and may be unnecessary.
• The current recommendations from the Danish Medicines Agency should be revised to incorporate new findings on statin safety and efficacy in liver disease.
• Further consideration of statins' role in managing chronic liver disease is warranted based on emerging research.